Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Revenue (2016 - 2025)

Surgery Partners' Revenue history spans 12 years, with the latest figure at $885.0 million for Q4 2025.

  • For Q4 2025, Revenue rose 2.38% year-over-year to $885.0 million; the TTM value through Dec 2025 reached $3.3 billion, up 6.24%, while the annual FY2025 figure was $3.3 billion, 6.24% up from the prior year.
  • Revenue for Q4 2025 was $885.0 million at Surgery Partners, up from $821.5 million in the prior quarter.
  • Across five years, Revenue topped out at $885.0 million in Q4 2025 and bottomed at $512.4 million in Q1 2021.
  • The 5-year median for Revenue is $690.6 million (2022), against an average of $696.5 million.
  • The largest annual shift saw Revenue soared 45.0% in 2021 before it increased 2.38% in 2025.
  • A 5-year view of Revenue shows it stood at $610.2 million in 2021, then rose by 15.88% to $707.1 million in 2022, then grew by 4.0% to $735.4 million in 2023, then grew by 17.54% to $864.4 million in 2024, then increased by 2.38% to $885.0 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Revenue are $885.0 million (Q4 2025), $821.5 million (Q3 2025), and $826.2 million (Q2 2025).